Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
Authors
Keywords
Fatty liver, Fibrosis, Liver fibrosis, Biopsy, Ghrelin, Cytokines, Steatosis, Resistin
Journal
PLoS One
Volume 16, Issue 11, Pages e0260313
Publisher
Public Library of Science (PLoS)
Online
2021-11-24
DOI
10.1371/journal.pone.0260313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
- (2021) David Petroff et al. Lancet Gastroenterology & Hepatology
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Current and future treatment options in non-alcoholic steatohepatitis (NASH)
- (2017) Nikos Lazaridis et al. Expert Review of Gastroenterology & Hepatology
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders
- (2015) Ming-Ling Chang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Reference intervals of plasma matrix metalloproteinases 2, 3, and 9 and serum asymmetric dimethylarginine levels
- (2015) Pavlina Kusnierova et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
- (2015) Sanja Stojsavljević WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays
- (2013) John Todd et al. CYTOKINE
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis
- (2013) K. Shimamoto et al. JOURNAL OF RHEUMATOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- From fatty liver to fibrosis: A tale of “second hit”
- (2013) Metin Basaranoglu WORLD JOURNAL OF GASTROENTEROLOGY
- Matrix metalloproteinase-9 contributes to parenchymal hemorrhage and necrosis in the remnant liver after extended hepatectomy in mice
- (2012) Norifumi Ohashi WORLD JOURNAL OF GASTROENTEROLOGY
- Role of cytokines and chemokines in non-alcoholic fatty liver disease
- (2012) Vincent Braunersreuther WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- (2010) J. K. Dowman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adiponectin: A Key Player in Obesity Related Disorders
- (2010) Yuji Matsuzawa CURRENT PHARMACEUTICAL DESIGN
- Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis
- (2010) Silvia Gaia et al. JOURNAL OF HEPATOLOGY
- An apoptosis panel for nonalcoholic steatohepatitis diagnosis
- (2010) Tarek I. Abu-Rajab Tamimi et al. JOURNAL OF HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
- (2009) Emmanuel A. Tsochatzis et al. MEDIATORS OF INFLAMMATION
- Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
- (2008) Dima L. Diab et al. Clinical Gastroenterology and Hepatology
- Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease
- (2008) Hong Ma et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started